Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer
Figure 3
Kaplan-Meier survival analysis by stratification of TNM staging. (a) In stage II, the NED(+) group had a significantly worse prognosis than the NED(−) group (). (b) In stage III, there was no significant difference in survival time between the NED(+) and NED(−) groups. (c) There was no significant difference in the survival times of stage II NED(+) and stage III patients (). However, the survival time of stage II NED(−) patients was significantly longer than stage II NED(+) patients () and stage III patients ().
